<DOC>
	<DOCNO>NCT00177866</DOCNO>
	<brief_summary>The investigator select 60 people 18-70 year age Crohn 's disease randomly assign receive 8-week trial celecoxib 8-week trial placebo . There 1-week interval `` wash-out '' trial participant take study medication . The investigator monitor participant 18 week start medication observe Crohn 's disease activity , assess flare-ups exacerbation disease possible side effect celecoxib . Based observation , determination make investigator safety celecoxib . If celecoxib find safe , may provide physician medication prescribe people Crohn 's disease experience chronic pain arthritis arthralgia .</brief_summary>
	<brief_title>Safety Celecoxib Patients With Crohn 's Disease</brief_title>
	<detailed_description>Please refer brief summary ( ) .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>1 . Greater 18 year age less 70 year age 2 . Confirmed diagnosis Crohn 's disease 3 . Inactive disease ( CDAI score baseline &lt; 150 ) active disease ( CDAI score baseline &lt; 200 ) . 1 . Pregnant , nurse mother woman childbearing potential use reliable contraception ( i.e . : oral contraceptive pill [ OCP ] , intrauterine device [ IUD ] , Norplant ) 2 . Enrolled study involve nonsteroidal antiinflammatory drug ( NSAID ) medication 3 . NSAID use time study 4 . Baseline moderate severe Crohn 's disease activity ( CDAI &gt; 200 ) 5 . Current treatment le 6 month mercaptopurine ( 6 MP ) immuran . 6 . Treatment current Crohn 's medication period le 3 month 7 . Surgery Crohn 's disease ( within 1 month ) 8 . Known sensitivity celecoxib , NSAIDs , sulfonamides 9 . History gastritis , gastrointestinal bleeding , peptic ulcer disease 10 . Advanced kidney disease 11 . Severe hepatic impairment 12 . Subjects currently take angiotensinconverting enzyme ( ACE ) inhibitor , furosemide , fluconazole , lithium , corticosteroid , warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>